Mark Evashenk

Mark Evashenk is a seasoned professional with extensive experience in clinical operations, currently serving as the Director of Clinical Operations at ALZA Corporation, a subsidiary of Johnson & Johnson Pharma, where Mark has been since 2006. In addition to this role, Mark also holds the title of Clinical Program Leader, demonstrating a strong commitment to advancing clinical programs and ensuring operational excellence within the organization.